IDEXX EVP and Chief Commercial Officer James Polewaczyk to retire April 1, 2024

IDEXX LABORATORIES INC /DE

James F. Polewaczyk, EVP and Chief Commercial Officer, notified retirement on Dec 5, 2023.
Effective date of retirement is April 1, 2024, after 17 years of service.
No replacement has been announced; search process not disclosed.

item 5.02

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

James F. Polewaczyk

Executive Vice President and Chief Commercial Officer

IDXX · IDEXX LABORATORIES INC /DE

Effective: 2024-04-01
Filed: December 7, 2023, 6:59 PM ET

On December 5, 2023, James F. Polewaczyk, Executive Vice President and Chief Commercial Officer of IDEXX Laboratories, Inc. (the “Company”), notified the Company of his intent to retire after more than 17 years of dedicated leadership and service, effective April 1, 2024.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 1.0

James F. Polewaczyk departed as Executive Vice President and Chief Commercial Officer at IDEXX LABORATORIES INC /DE.

Action: notified his intent to retire
Role: Executive Vice President and Chief Commercial Officer

Exact text from the filing

On December 5, 2023, James F. Polewaczyk, Executive Vice President and Chief Commercial Officer of IDEXX Laboratories, Inc. (the “Company”), notified the Company of his intent to retire after more than 17 years of dedicated leadership and service, effective April 1, 2024.

View on SEC.gov

IDEXX LABORATORIES INC /DE filing history →

Source: SEC EDGAR

accession 0000874716-23-000143

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.